ClinVar Miner

Submissions for variant NM_000179.2(MSH6):c.2281A>G (p.Arg761Gly) (rs199876321)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000129031 SCV000172939 uncertain significance Hereditary cancer-predisposing syndrome 2018-03-01 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Insufficient or conflicting evidence
Invitae RCV000195792 SCV000254294 uncertain significance Hereditary nonpolyposis colon cancer 2018-12-19 criteria provided, single submitter clinical testing This sequence change replaces arginine with glycine at codon 761 of the MSH6 protein (p.Arg761Gly). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and glycine. This variant is present in population databases (rs199876321, ExAC 0.03%). This variant has not been reported in the literature in individuals with MSH6-related disease. ClinVar contains an entry for this variant (Variation ID: 140836). An algorithm developed specifically for the MSH6 gene suggests that this variant is likely to be deleterious (PMID: 23621914). General algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). These predictions have not been confirmed by published functional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV000657020 SCV000279316 uncertain significance not provided 2018-10-15 criteria provided, single submitter clinical testing This variant is denoted MSH6 c.2281A>G at the cDNA level, p.Arg761Gly (R761G) at the protein level, and results in the change of an Arginine to a Glycine (AGG>GGG). This variant was observed in several individuals that underwent testing for hereditary colon cancer, one of which was also identified to have a single MUTYH pathogenic variant (Rey 2017, Ricker 2017, Martin-Morales 2018). MSH6 Arg761Gly was also identified in an individual with a personal history of melanoma (Yehia 2018). MSH6 Arg761Gly was observed at an allele frequency of 0.035% (12/33,574) in individuals of Latino ancestry in large population cohorts (Lek 2016). This variant is located in the Lever domain (Warren 2007, Kansikas 2011). In-silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect. Based on currently available evidence, it is unclear whether MSH6 Arg761Gly is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000657020 SCV000601528 uncertain significance not provided 2019-05-17 criteria provided, single submitter clinical testing
Color RCV000129031 SCV000685275 uncertain significance Hereditary cancer-predisposing syndrome 2018-09-03 criteria provided, single submitter clinical testing
Counsyl RCV000662484 SCV000784983 uncertain significance Hereditary nonpolyposis colorectal cancer type 5 2017-03-22 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.